Cargando…
Superion(®) InterSpinous Spacer for treatment of moderate degenerative lumbar spinal stenosis: durable three-year results of a randomized controlled trial
PURPOSE: This report provides the 3-year clinical outcomes from the randomized, controlled US Food and Drug Administration Investigational Device Exemption trial of the Superion(®) for the treatment of moderate degenerative lumbar spinal stenosis. PATIENTS AND METHODS: The Superion(®) was evaluated...
Autores principales: | Patel, Vikas V, Nunley, Pierce D, Whang, Peter G, Haley, Thomas R, Bradley, W Daniel, Davis, Raphael P, Block, Jon E, Geisler, Fred H |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4599047/ https://www.ncbi.nlm.nih.gov/pubmed/26491369 http://dx.doi.org/10.2147/JPR.S92633 |
Ejemplares similares
-
Minimally Invasive Treatment of Moderate Lumbar Spinal Stenosis with the Superion(®) Interspinous Spacer
por: Bini, Walter, et al.
Publicado: (2011) -
Five-year durability of stand-alone interspinous process decompression for lumbar spinal stenosis
por: Nunley, Pierce D, et al.
Publicado: (2017) -
Two-year clinical outcomes of a multicenter randomized controlled trial comparing
two interspinous spacers for treatment of moderate lumbar spinal stenosis
por: Patel, Vikas V, et al.
Publicado: (2014) -
Interspinous Process Decompression With The Superion(®) Spacer For Lumbar Spinal Stenosis: Real-World Experience From A Device Registry
por: Tekmyster, Gene, et al.
Publicado: (2019) -
Interspinous Process Decompression Improves Quality of Life in Patients with Lumbar Spinal Stenosis
por: Nunley, Pierce D., et al.
Publicado: (2018)